PharmaKnowl Consulting participated as an exhibitor at the World Patient Safety Congress Europe 2026, held on 23–24 September 2026 at RAI Amsterdam, Netherlands. The event brought together pharmaceutical and biotechnology companies, healthcare professionals, regulators, patient safety experts, and industry stakeholders to discuss the latest developments in patient safety, pharmacovigilance, risk management, and regulatory compliance.

Throughout the two-day congress, the PharmaKnowl team welcomed visitors at booth engaging with professionals from across the global life sciences industry and discussing the evolving pharmacovigilance and regulatory requirements for companies operating in or planning to enter the Saudi Arabian market.

The congress provided an opportunity for PharmaKnowl’s pharmacovigilance specialists to exchange insights with international organizations on the practical challenges of establishing and maintaining compliant safety systems in Saudi Arabia. Discussions at the booth covered a range of pharmacovigilance topics, including Local QPPV requirements, Pharmacovigilance System Master File (PSMF) and Pharmacovigilance System Summary File (PSSF) requirements, Individual Case Safety Report (ICSR) processing, literature monitoring, signal detection, aggregate reporting, Risk Management Plans (RMPs), and ongoing SFDA compliance.

The team also discussed the importance of building pharmacovigilance systems that are not only compliant with Saudi regulatory requirements but also effectively integrated with global safety processes. For international pharmaceutical and biotechnology companies, understanding how local Saudi requirements connect with global pharmacovigilance frameworks is an important consideration when establishing or expanding operations in the Kingdom.

Beyond the technical discussions, the congress provided PharmaKnowl with an opportunity to connect with professionals and organizations from different parts of the global life sciences industry. Conversations at the event highlighted the growing need for practical regulatory and pharmacovigilance support as companies expand into new markets and navigate increasingly complex safety and compliance requirements.

Participation in the World Patient Safety Congress Europe 2026 further strengthened PharmaKnowl’s engagement with the international patient safety and pharmacovigilance community and provided valuable opportunities to exchange knowledge, understand industry needs, and build connections with organizations working to improve medicine safety. We look forward to continuing these conversations and supporting organizations seeking to establish and maintain compliant pharmacovigilance systems in Saudi Arabia and the wider GCC region.